Immunotherapy and PARP inhibitors as first-line treatment in endometrial cancer: A systematic review and network meta-analysis
Guillermo Villacampa, Gemma Eminowicz, Víctor M. Navarro, Lorenzo Carità, David García-Illescas, Ana Oaknin, José Alejandro Pérez Fidalgo
Topics & Concepts
Meta-analysisEndometrial cancerMedicineOncologyInternal medicineFirst lineImmunotherapyFirst line treatmentGynecologyCancerChemotherapyEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersPARP inhibition in cancer therapy